


FidoCure®
Biotechnology Research • Palo Alto, California, United States • 11-20 Employees
Company overview
| Headquarters | 228 Hamilton Ave, Palo Alto, California 94301, US |
| Phone number | +14152738863 |
| Website | |
| Keywords | Clinical Trials, Animal Health, Saving Lives, Veterinary Clinical Trials, Veterinary Oncology, Comparative Medicine, Ai Enabled Precision Medicine |
| Founded | 2018 |
| Employees | 11-20 |
| Socials |
Key Contact at FidoCure®
Christina Lopes
Ceo & Founder
FidoCure® Email Formats
FidoCure® uses 4 email formats. The most common is {first initial} (e.g., j@fidocure.com), used 50% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@fidocure.com | 70% |
{first name} | john@fidocure.com | 30% |
About FidoCure®
FidoCure is the first and only service to offer cancer care with a dual-focus approach that benefits both dogs and humans. Leveraging the genetic similarities between human and canine cancers, FidoCure offers targeted therapies that allow for more effective treatments extending dog lives by up to 3x. Through our Next Generation DNA Sequencing Test, the first of its kind to introduce human-grade targeted treatments to our canine companions, we have assembled the world's largest canine cancer genomics database which uses genomic testing to provide veterinarians with critical data, enabling them to tailor the most effective targeted therapies for each individual dog patient. You can view our peer reviewed research in Nature Precision Oncology Journal and Nature Scientific Reports. FidoCure is proud to be leading precision medical research in canine oncology, and our team is committed to revolutionizing the way cancer care is delivered to dogs and humans alike. Our technology provides advanced diagnostics and facilitates access to precision medicines at the touch of a button. FidoCure by the One Health Company is backed by premier biotech investors including Polaris Ventures, A16Z, and YCombinator. Our vision along with our stakeholders, is a world free of cancer achieved by cost-effective, personalized precision medicine for both humans and their canine companions. Learn more at www.fidocure.com.
FidoCure® revenue & valuation
| Annual revenue | $3,000,000 |
| Revenue per employee | $150,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $9,600,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
FidoCure® has 5 employees across 4 departments.
Departments
Number of employees
Funding Data
FidoCure® has never raised funding before.
FidoCure® Tech Stack
Discover the technologies and tools that power FidoCure®'s digital infrastructure, from frameworks to analytics platforms.
Video players
JavaScript libraries
JavaScript libraries
Analytics
WordPress themes
Page builders
JavaScript libraries
CDN
Font scripts
WordPress themes
JavaScript libraries
Analytics
Frequently asked questions
4.8
40,000 users



